Recombinant human interleukin-11 (Diao group)
重组人白介素-11（地奥集团）
Report date: 2022/01/14 13:23:58
Base Information
Drug NameRecombinant human interleukin-11 (Diao group)
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved Indications
Approved Indications in China
Original Approved Country/Territory
Original Approved Date2003/04/23
Country/Territory
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesChengdu Diao Jiuhong Pharmaceutical Factory
China Registration ClassN/A
Develop Information
Active CompaniesChengdu Diao Jiuhong Pharmaceutical Factory
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC Code
Related LinksN/A